Peptide Half-Life Chart & Visualizer

Understanding Peptide Half-Lives

A peptide's half-life is the time required for its concentration in your body to reduce to 50% of its initial level. This fundamental pharmacokinetic parameter determines how quickly your body metabolizes and eliminates the peptide. Understanding half-life is crucial because it directly influences how frequently you need to dose and how long it takes to reach therapeutic steady-state levels.

Peptides vary dramatically in their half-lives—from minutes (like DSIP and GHRP-6) to weeks (like Semaglutide and Tirzepatide). Short half-life peptides require frequent dosing but allow rapid adjustments if side effects occur, while long half-life peptides offer convenience with less frequent dosing but take longer to reach therapeutic levels and clear from your system.

The half-life is determined by factors including the peptide's molecular structure, whether it's conjugated (like CJC-1295 with DAC), the route of administration (injectable vs. intranasal vs. topical), and your individual metabolism. Liver and kidney function, age, and other medications can all influence how quickly you metabolize peptides.

Why Half-Life Matters for Dosing

Dosing frequency should align with a peptide's half-life to maintain consistent therapeutic levels and achieve steady state efficiently. If you dose too infrequently relative to the half-life, concentrations will drop below therapeutic levels before the next dose, reducing efficacy. If you dose too frequently, the peptide accumulates, potentially increasing side effects.

Steady state—where drug elimination equals drug input—is reached after approximately 3-5 half-lives. For example, BPC-157 with a 4-hour half-life reaches steady state in 12-20 hours of consistent dosing (2x/day), while Semaglutide's 7-day half-life means steady state takes 3-5 weeks of weekly dosing. Understanding this timeline helps you know when to expect full therapeutic benefits.

The visualizer above shows redosing points (marked with circles) that indicate optimal timing for your next dose to maintain steady therapeutic levels. Reference the dotted line at 50% to see when each peptide reaches half its peak concentration—a key threshold for redosing decisions.

Short vs Long Half-Life Peptides

Short half-life peptides (minutes to a few hours) include DSIP, Selank, GHRP-6, GHRP-2, Sermorelin, and Exenatide. These require 2-3 daily dosings but offer rapid onset and offset of effects. They're ideal for targeted therapeutic windows (like dosing DSIP at night for sleep or GHRP-6 before meals) and allow quick response if adverse effects occur. However, consistent adherence to dosing schedules is critical.

Long half-life peptides (days to weeks) include Semaglutide, Tirzepatide, Retatrutide, and CJC-1295 DAC. These require only weekly dosing, making compliance easier and allowing more stable, steady-state levels with less fluctuation. The tradeoff is slower onset of benefits and longer clearance times if you need to discontinue. They're excellent for metabolic health, weight management, and GH stimulation goals requiring consistent, long-term action.

Intermediate peptides (4-24 hours) like BPC-157, TB-500, MK-677, and Liraglutide strike a balance, typically requiring once or twice-daily dosing with moderate steady-state achievement timelines (12-48 hours). These are versatile for recovery, healing, and metabolic support with practical dosing schedules.

How to Optimize Your Dosing Schedule

Start by identifying each peptide's recommended dosing frequency (shown in the details panel above) and align it with your lifestyle and goals. For morning energy or cognitive function, dose short half-life peptides like Semax at breakfast. For sleep support, use DSIP nightly. For sustained metabolic benefits, commit to weekly injections of Semaglutide or Tirzepatide.

Track your response over the first 3-5 half-lives to assess efficacy. During this period, you're reaching steady state and can evaluate whether your current dose is providing desired results. Keep detailed logs of dosing times, amounts, and how you feel—this is invaluable for fine-tuning. If using multiple peptides, stagger their dosing schedules when possible to reduce injection burden and simplify your routine.

Consider your individual factors: liver and kidney function affect clearance, body composition influences distribution, and concurrent medications may interact. When in doubt, start at the lower end of recommended dose ranges and gradually increase while monitoring response. Use tools like our peptide calculator to determine exact reconstitution and dosing volumes, and consult our guides on proper injection technique and peptide storage and stability.

Related Tools & Guides

Complement this half-life visualizer with our comprehensive suite of peptide resources to build a complete understanding of your protocols.

• Peptide Calculator – Precisely calculate reconstitution ratios, injection volumes, and microdosing conversions.
• Semaglutide Dosing Chart – Detailed tiered dosing guide for GLP-1 receptor agonists.
• BPC-157 Dosage Guide – Complete protocol for this popular healing and recovery peptide.
• How to Inject Peptides – Step-by-step instructions for safe, sterile injection technique.
• Peptide Storage & Stability – Best practices to preserve potency and extend shelf life.
• BPC-157 Profile – In-depth research, benefits, and protocols.
• Semaglutide Profile – Everything about this GLP-1 agonist for weight and metabolic management.

Whether you're optimizing a simple single-peptide protocol or running a sophisticated multi-peptide stack, these resources work together to help you dose intelligently, inject safely, and maximize results. Visit our complete guides library for more educational content.